Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Lexaria Bioscience Corp. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q4 2022
- Shares held
- 679.2K
- −17.9K (−2.6%) vs. Q4 2022
- Total value
- $1.85M
- +$135.6K (+7.9%) vs. Q4 2022
- New holders
- 2
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $920.0K |
| Q1 2026 | 28 | $1.17M |
| Q4 2025 | 21 | $1.05M |
| Q3 2025 | 25 | $1.63M |
| Q2 2025 | 21 | $2.00M |
| Q1 2025 | 22 | $2.12M |
| Q4 2024 | 25 | $3.03M |
| Q3 2024 | 27 | $3.25M |
| Q2 2024 | 28 | $5.72M |
| Q1 2024 | 25 | $3.23M |
| Q4 2023 | 20 | $1.49M |
| Q3 2023 | 15 | $1.77M |
| Q2 2023 | 14 | $651.4K |
| Q1 2023 | 17 | $1.85M |
| Q4 2022 | 16 | $1.71M |
| Q3 2022 | 16 | $1.68M |
| Q2 2022 | 16 | $1.67M |
| Q1 2022 | 12 | $1.41M |
| Q4 2021 | 13 | $1.85M |
| Q3 2021 | 11 | $2.83M |
| Q2 2021 | 10 | $2.93M |
| Q1 2021 | 9 | $1.78M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invenomic Capital Management LP | 473,103 | $1.29M | 0.07% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 67,452 | $183.5K | 0.00% | +1,321+2.0% | Added |
| Geode Capital Management, LLC | 48,837 | $132.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 33,329 | $90.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,268 | $41.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 13,600 | $37.0K | 0.00% | +2,100+18.3% | Added |
| Centiva Capital, LP | 12,059 | $32.8K | 0.00% | −1,000−7.7% | Reduced |
| UBS Group AG | 4,639 | $12.6K | 0.00% | −957−17.1% | Reduced |
| Tower Research Capital LLC (TRC) | 4,089 | $11.0K | 0.00% | −935−18.6% | Reduced |
| 1832 Asset Management L.P. | 2,686 | $7.30K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,043 | $5.56K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,069 | $2.91K | 0.00% | +34+3.3% | Added |
| Aspire Private Capital, LLC | 400 | $1.09K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 394 | $1.00K | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 166 | $452 | 0.00% | +166 | New |
| Gables Capital Management Inc. | 13 | $35 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 13 | $0 | 0.00% | +13 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,674−100.0% | Sold out |